Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial.

L Viladomiu1, J Genescà, J I Esteban

  • 1Department of Medicine, Hospital General Universitari Vall d'Hebron, Barcelona, Spain.

Hepatology (Baltimore, Md.)
|May 1, 1992
PubMed
Summary

Interferon-alpha treatment for acute hepatitis C showed short-term improvements in liver enzymes but no long-term benefits. This hepatitis C treatment was safe, though, with no significant side effects observed in patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Face-straight-down and face-near-straight-down positions in healthy, prone-sleeping infants.

The Journal of pediatrics·1996
Same author

Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less.

The Journal of pediatrics·1996
Same author

[Human babesiosis in a patient after splenectomy].

Medicina clinica·1996
Same author

Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

Proceedings of the National Academy of Sciences of the United States of America·1996
Same author

Effect of in vivo activation of natural killer (NK) cells by a tilorone analogue on the survival of mice injected intravenously with different experimental murine tumours.

Clinical and experimental immunology·1996
Same author

The effect of temperature on charge movement repriming in amphibian skeletal muscle fibers.

The American journal of physiology·1996

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Acute hepatitis C is a significant public health concern.
  • Posttransfusion hepatitis C requires effective treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy of interferon-alpha in treating acute posttransfusion hepatitis C.
  • To assess the safety and long-term outcomes of interferon-alpha therapy.

Main Methods:

  • Randomized controlled trial involving 28 patients with acute hepatitis C.
  • Interferon-alpha treatment group received 3 million units thrice weekly for 12 weeks.
  • Biochemical, histological, and serological parameters monitored over 1 year.

Main Results:

  • Short-term normalization of ALT levels observed in 73% of treated patients vs. 38% of controls (p=0.06).

Related Experiment Videos

  • Differences in ALT normalization disappeared at 6 and 12 months.
  • Delayed and lower rate of anti-hepatitis C virus seroconversion in the interferon-alpha group.
  • Trend towards less severe hepatic lesions in treated patients, but no statistical significance.
  • No severe adverse events associated with interferon-alpha therapy.

    • Conclusions:

    • A 3-month course of interferon-alpha is safe for acute hepatitis C.
    • Interferon-alpha may temporarily reduce disease activity during treatment.
    • No long-term benefits of interferon-alpha on hepatitis C outcomes were demonstrated, possibly due to small sample size.